Evolent Health, Inc.

EVH

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001628908-26-000019
Filing date: Mar 4, 2026
Earliest execution date: Mar 1, 2026

Summary

Type

Sell

Net shares

-6,052

% of shares

-8.30%

Amount (USD)

$26,549

Insider confidence score

46.3 out of 100

Positive

  • Tax withholding obligation
  • Small sell amount (<$50K)

Negative

  • Large tax withholding sell (≥1% of shares)

Stock transactions

Transaction 1

Security

Class A Common Stock

Action

Tax_withhold

Date

2026-03-01

Code

F

Net shares

-2,577.0

Price per Share

$3.25

Amount (USD)

$8,375.25

Acquired/Disposed

Disposed

Shares Owned Before

72,899.0

Shares Owned After

70,322.0

Transaction 2

Security

Class A Common Stock

Action

Grant

Date

2026-03-02

Code

A

Net shares

+1,686.0

Acquired/Disposed

Acquired

Shares Owned Before

70,322.0

Shares Owned After

72,008.0

Transaction 3

Security

Class A Common Stock

Action

Tax_withhold

Date

2026-03-02

Code

F

Net shares

-850.0

Price per Share

$3.58

Amount (USD)

$3,043.00

Acquired/Disposed

Disposed

Shares Owned Before

72,008.0

Shares Owned After

71,158.0

Transaction 4

Security

Class A Common Stock

Action

Tax_withhold

Date

2026-03-03

Code

F

Net shares

-4,311.0

Price per Share

$3.51

Amount (USD)

$15,131.61

Acquired/Disposed

Disposed

Shares Owned Before

71,158.0

Shares Owned After

66,847.0

Derivative Transactions

Transaction 1

Security

Performance-Based Share Unit

Action

Grant

Date

2026-03-02

Code

A

Net shares

+55,173.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

55,173.0

Filing's footnotes

1. This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

2. Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

3. Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2024, following the certification ofachievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 2, 2026. The shares underlying the PSU award vested at the conclusion ofthe performance period on December 31, 2025.

4. This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units.

5. Represents performance-based share units (PSUs) granted to Mr. Shams pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions. Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.